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Abstract
Background: Association of High-risk Human Papillomavirus (HR-HPV) with oral cancer has been established
recently. Detecting these viruses in oral cavity is important to prevent oral lesions related to them. The purpose of
this study was to evaluate the prevalence of HR-HPV in the oral cavity of women with cervical cancer, and their
children. A total of 70 women, previously diagnosed with cervical cancer, and 46 children of these women, born
by vaginal delivery only, were selected for this study. Buccal swabs were collected from their oral cavity and HPV
detection was carried out using Hybrid Capture 2 high-risk HPV (HC2 HR-HPV) detection system.
Results: Out of 70 women with cervical cancer, four (5.71%) were found to be positive for HR-HPV in their oral
cavity. No association of HR-HPV was found with sociodemographic profile, marital status, reproductive history,
tobacco and alcohol usage, contraceptive pills usage, and presence of oral lesions (p>0.05). Among children, HR-
HPV in the oral cavity was detected in only 1 of the 46 subjects examined (2.17%). Clinically healthy oral mucosa,
without any oral lesions, was observed in all the HR-HPV positive subjects.
Conclusion: The result of this study showed that there is low, if any, risk of HR-HPV infection in the oral cavity of
women with cervical cancer. Further, our study suggests that there is very low risk for children of women with
cervical cancer, to acquire and sustain HR-HPV in their oral cavity until childhood or adolescence.
Background
Human Papillomavirus (HPV) is an epitheliotropic, dou-
ble stranded, circular DNA virus from Papovavirus
family [1], which is found to infect cells in the basal
layer of squamous epithelium [2]. Thus, infection caused
b yH P Vi sf o u n di nv a r i o u sb o d ys i t e s ,s u c ha sa n o g e n -
ital tract, skin, conjunctiva, larynx, tracheobronchial
mucosa, esophagus and oral cavity [3]. Over the years,
more than 130 types of HPV have been identified
according to the nucleotide sequence alignment of its
open reading frames [4]. HPV is also classified as low-
risk and high-risk type, depending on its potential to
cause malignant lesions such as cervical carcinomas [5].
In up to 92% of cervical malignancies, certain types of
high-risk (HR) HPVs have been identified [6]. HR-HPV
oncoproteins (E6 & E7) act by disrupting the function
of tumor suppressor genes (pRb & p53), leading to
excessive cell growth [1].
A recent meta-analysis has established HPV as an
independent risk factor for oral carcinomas as well [7].
Our recent study done in 105 oral squamous cell carci-
nomas (OSCC) affecting Malaysian population also
found HPV to be significantly associated with OSCCs (P
< 0.001, OR = 4.3) [8]. As seen in anogenital cancers,
HR-HPV 16 is the most common HPV type found in
oral carcinomas. Other oncogenic types seen in oral car-
cinomas include HPV 18, 31 and 33 [9]. Thus, it is
imperative to detect HR-HPV in the oral cavity, as
otherwise, these might cause benign or malignant HPV
related oral lesions like papillomas and oral squmaous
cell carcinomas in future. Several studies have been car-
ried out to obtain the relationship of concurrent infec-
tion by HPV in cervical and oral sites [10,11].
Different methods have been used to detect HPV in
concurrent infections giving varied results. PCR is used
in many studies and it is known to be very sensitive in
detection of HPV [12]. The Digene HC2® assay is United
States Food and Drug Administration (USFDA)
approved commercially available kit. HC2® assay is a
nonradioactive, immuno-chemiluminescence method
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RNA probes to HPV genomic sequence. Compared with
PCR, HC2® has excellent clinical sensitivity, almost up
to 100%, as it shows only positive result when risk of
disease progression exists. Studies have shown that
HC2® is comparable to PCR and thus, it can be used as
an adjunct or stand-alone test in HPV detection [13].
While the HPV related genital lesions are more fre-
quently seen in adults, lesions like skin warts, oral and
laryngeal papillomas are more frequently seen in chil-
dren [14]. Further, the mode of viral transmission in
children remains contentious. Several potential modes
of transmission have been proposed for these pediatric
HPV infections, which include non-sexual routes, like
perinatal vertical transmission, auto- and hetero-inocula-
tion, indirect transmission via fomites, and sexual ways,
like sexual abuse [15,16]. Hajek suspected vertical trans-
mission of juvenile onset recurrent respiratory papillo-
matosis (RRP), a relatively rare disease caused by HPV,
from a mother to her child at birth, as early as 1956
[17]. Since then, several studies have been published giv-
ing results which vary from as low as 0% to as high as
80% [18-20]. An argument against these earlier studies
w a st h a ta st h es a m p l e sw e r et a k e na tt h et i m eo f ,o r
soon after delivery, the HPV that was being detected in
such samples may actually reflect a surface contamina-
tion of the infant with HPV infected maternal cells,
rather than infection itself [21].
Therefore, the purpose of this study was to detect the
prevalence of HR-HPV in the oral cavity of women with
cervical cancer, and to evaluate the risk factors which
contribute to its occurrence. Also, this study aimed to
detect the existence of HR-HPV in children of the
women with cervical cancer, for evaluation of vertical
transmission of this virus, and to assess any associated
risk factors.
Results
Demographic profile of women with cervical cancer, and
their children
In total, 70 women diagnosed with cervical cancer and 46
children of these women, were recruited for this study.
The demographic profile of the women and their children
is given in Table 1 and Table 2 respectively. More than
two-third of the women examined (68.5%), were above 50
years of age, with the mean age of 55.21 years. Most of the
subjects were Malay (82.9%) and married (84.3%). Most of
the women did not have any tobacco or alcohol habits.
For children, 82.6% were from 11 to 18 years of age, with
the mean age of 14.78 years. There were more female chil-
dren (54.3%) than males (45.7%). Most of the children did
not have any tobacco or alcohol habits.
Table 1 Demographic profile of women with cervical
cancer
Variables n (n = 70) %
Age range
30-39 4 5.7
40-49 18 25.7
50-59 22 31.4
60 & above 26 37.1
Mean ± SD 55.21 ± 9.57
Race
Malay 58 82.9
Chinese 11 15.7
Indians 1 1.4
Marital status
Married 59 84.3
Single 1 1.4
Divorce 2 2.9
Remarried 8 11.4
Age when married
<18 years old 33 47.1
> 18 years old 37 52.9
Number of children
< 5 26 37.1
>5 44 62.9
Habits
Tobacco 3 4.3
Alcohol 4 5.7
Pregnancy and contraception
Pregnant 2 2.9
OCP usage 24 34.3
Table 2 Demographic profile of children of women with
cervical cancer
Variables (n = 46) %
Age range
1-5 2 4.3
6-10 6 13.0
11-15 16 34.8
16-18 22 47.8
Mean ± SD 14.78 ± 4.69
Race
Malay 44 95.7
Others 2 4.3
Gender
Male 21 45.7
Female 25 54.3
Habits
Tobacco 3 6.5
Alcohol 1 2.2
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Four samples (5.71%) from the oral cavity of women
with cervical cancer showed positivity for HR-HPV
using HC2® detection system, with RLU/CO value being
>1. Among the children, only 1 (2.17%) sample was
found to be positive for HR-HPV in the oral cavity. All
the positive subjects showed clinically healthy oral
mucosa without any lesions. Association of HPV in cer-
vical cancer subjects was evaluated with age range, eth-
nicity, marital status, age when got married, number of
children, pregnancy status, contraceptive pills usage,
tobacco and alcohol habits, and any oral lesions. Chi
square/Fisher’s Exact test showed no significant associa-
tion between HR-HPV infection with any of these vari-
ables (p > 0.05) (Table 3). As the percentage of HPV
positivity was very low in children (1/46, 2.17%), no sta-
tistical analysis was performed.
Discussion
Various studies have been conducted to study the role
of HPV in oral lesions and malignancies. However, the
association of HPV between cervical and oral cavity
remains unclear. Further, recent studies on mother-to-
child transmission by perinatal infection with HPV have
been inconclusive [15]. Considering the fact that almost
all the cervical cancers are caused by HPV [22], this
study was conducted to evaluate the prevalence of HR-
HPV in the oral cavity of women with cervical cancer,
and their children. To our knowledge, this is the first
study that has been carried out simultaneously in
women with cervical cancers, and their children, to
detect the presence of HR-HPV in their oral cavity.
Our results showed the prevalence of HR-HPV in oral
cavity of women with cervical cancer to be quite low,
with only 4 out of 70 subjects (5.71%) testing positive
for HR-HPV. The results found in this study were in
c o n c o r d a n c ew i t ht h es t u d yd o n eb yK e l l o k o s k iet.al
[23], which examined the cytological scrapings of oral
mucosa in 309 women with genital HPV infections, by
using dot blot hybridization and found oral HPV infec-
tion in only 3.8% women. Of these, only 2 had clinical
lesions suggestive of HPV infection. In our study, all the
HPV positive subjects had clinically normal oral mucosa.
Another study, that was done to determine the HPV
prevalence and concurrent infection in the cervix and
oral cavity of 577 pregnant women, found 29% positivity
in the cervix and 2.4% positivity in the oral cavity. No
association was found between HPV positivity and its
types detected in the cervix and oral cavity of these
women, suggesting that self-inoculation was rare [24].
While recent studies have shown the presence of HR-
HPV in a faction of oral pre-malignant and malignant
l e s i o n s ,t h i sm a ys u g g e s tar o l eo fH P Vi no n l yap o r t i o n
of oral malignancies, contrary to cervical region, where
its association is noted in almost all the cervical malig-
nancies [25]. This difference in HPV invasiveness could
be due to various factors. Firstly, oral cavity is in direct
contact with carcinogens present in tobacco and alcohol,
making them the primary cause of oral carcinogenesis.
This is not the case with cervical region, where there is
no direct contact with these carcinogens. Secondly, the
low prevalence of oral HPV infection might be due to the
body’s immune response, like immunoglobulin IgA and
proteolytic enzymes in the saliva that protect the oral
mucosa from viral infections [26]. Thirdly, antibodies
produced by the body in response to initial infection, in
this case cervical infection, might as well protect the
Table 3 Association of HR-HPV in the oral cavity of
women with cervical cancer, with variables
Variable n HPV positive n (%) X
2 p value
a
Age range
30-39 4 0 (0) 4.06 -
40-49 18 0 (0)
50-59 22 3 (13.6)
60 & above 26 1 (3.8)
Ethnicity
Malay 58 2 (3.4) 3.22 0.133
Others 12 2 (16.7)
Marital Status
Married 59 4 (6.8) 0.79 -
Single 1 0 (0)
Divorced 2 0 (0)
Remarried 8 0 (0)
Age when married
<18 years old 33 1 (3.0) 0.84 0.352
> 18 years old 37 3 (8.1)
No of children
< 5 26 2 (7.7) 0.30 0.476
>5 44 2 (4.5)
Pregnant
Yes 2 0 (0) 0.13 0.888
No 68 4 (5.9)
OCP usage
Yes 24 0 (0) 2.21 0.178
No 46 4 (8.7)
Tobacco usage
Yes 3 0 (0) 0.19 0.836
No 67 4 (6.0)
Alcohol consumption
Yes 4 0 (0) 0.26 0.786
No 66 4 (6.1)
Oral lesions
Yes 6 0 (0) 0.398 0.693
No 64 4 (6.3)
aFisher’s- exact test
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other sites. Fourthly, although the oral mucosal epithe-
lium resembles the epithelium of the genital tract [27],
antimicrobial action of saliva, along with its cleansing
and lubricating properties, may reduce the possibility of
virus entry into the oral epithelial cells by reducing the
contact period of the virus with the oral mucosa [28].
Finally, considering the HPV detection method, although
cytological scraping has many advantages, like being
painless and non-invasive method, thus having better
patient compliance compared to invasive procedures like
biopsy, the disadvantage of this technique is that, in
scrapings, basal and parabasal cells cannot be collected,
which could lead to false negative results. Failure to col-
lect the infected cells from basal layers might have also
contributed to the low prevalence found in our study.
In contrast to our findings, a higher percentage (15.4%
and 29.4%) of concurrent HPV infection between clini-
cally normal oral mucosa and genital region, by using
Southern blot and PCR procedures respectively, was
obtained by Kellokoski et.al [29]. In another study,
Badaracco et.al studied concurrent HPV infection in
oral & genital mucosa by using PCR based assay. Sixteen
subjects positive for HPV (31.25%) showed simultaneous
genital & oral cavity infections, while HPV type-specific
concordance was detected in only 3 patients [10]. These
differences in prevalence could be due to sensitivity of
the assays used, and differences in sample size. Most of
the previous studies were conducted using PCR based
assays for HPV detection. PCR is highly sensitive with
detection limits between 10-400 copies of HPV DNA
resulting in detection of clinically insignificant viral
levels which can be cleared by our own immune system.
HC2®, on the other hand, detects clinically relevant viral
levels, that is 5000 copies and above [30]. At these viral
levels, the probability of developing HR-HPV disease is
high. Thus, prevalence obtained in studies that used
PCR as HPV DNA detection assay will be higher as
compared to HC2®. Moreover, HC2® detects only 13
types of HR-HPVs, while PCR based assays detect all
types of HPVs.
Our study did not find any association of HPV in cer-
vical cancer subjects with age range, ethnicity, marital
status, number of children, tobacco or alcohol usage,
contraceptive pills usage, or any oral lesions. This could
be due to small percentage of positivity seen in our
results and smaller sample size. Studies have shown that
smoking has potential to alter oral epithelium, thus it
has an influence on HPV expression in oral cavity [31].
However, as most of the subjects in this study (94.29%)
were non-smokers and non-alcoholics, any association
with oral habits could not be established.
This study did not assess the presence of HPV in the
genital regions of women with cervical cancers at the
time of examining their oral cavity for HR-HPV. It is
because this study was more focused on detecting HR-
HPV in the oral cavity, which might cause benign or
malignant HPV related oral lesions in their future,
rather than detecting concurrent infections in genital
and oral regions, as reported in previously mentioned
studies.
This study also aimed to detect the presence of HPV
in oral cavity of the children of these women. Only 1 of
the 46 children analysed was found to be positive for
oral HR-HPV (2.17%). Further questioning from this
HR-HPV positive subject revealed that he was sexually
active. Thus, the positivity could be, in part, due to the
sexual activities rather than transmission from the
mother. Similar to our results, Koch et al tested the pre-
sence of HPV in the anal region and the oral cavity of
Danish children, aged 0 to 17 years, by PCR targeting
the L1 region of the HPV genome. Only four of the 249
anal samples and one of 392 oral samples were found to
be HPV positive. The authors concluded that ano-geni-
tal types of HPV are not transmitted by non-sexual
routes, and that HPV infection mainly occurs later in
life [32].
Children of older age groups were chosen for analysis
in our study. This is because the infants were shown to
have a higher percentage of oral HPV, which could be
due to the result of surface contamination that might
occur in these infants during childbirth rather than
HPV infection per se [33]. This finding was reconfirmed
by a recent study in which all the HPV-DNA positive
newborns (22.4%) at birth and at the end first month of
life (6.1%) became HPV-DNA negative by the age of 6
months [34]. Similarly, in 1986, Roman and Fife ana-
lysed the foreskins of 70 male infants undergoing rou-
tine circumcision for HPV type 6, 11, 16, and 18, by
using dot blot hybridization and found HPV in 4% of
the cases. The result suggest e dt h a tn e o n a t e se x h i b i ta
relatively high incidence of exposure to HPV during or
before birth. However, no correlation could be identified
between mothers with abnormal pap smears and the
HPV-positive foreskins [35]. Another recent study ana-
lysed 49 HPV DNA-positive pregnant women at the
time of delivery and found 24.5% placentas had a posi-
tive result for HPV DNA. Eleven newborn were HPV
DNA positive in samples from the nasopharyngeal or
buccal and body or cord blood. Out of these, 5 cases
(10.2%) had HPV type-specific agreement between geni-
tal/placenta/newborn samples suggesting transplacental
transmission [36]. Other studies have also supported the
concept that maternal genital-tract HPV infection could
cause other diseases like respiratory [37] and laryngeal
papillomas [38] in children. Oral HPV prevalence in
children has also been reported by few researchers
[39,40]. Studies on newborn babies have detected a
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nasopharyngeal aspirates or buccal swabs [41-43].
Our study was cross-sectional as compared to several
other studies which were longitudinal, starting from the
HPV detection since the mother became pregnant, until
the delivery or a few months after birth [20,21,44,45].
Based on our results, which showed very low HR-HPV
positivity, we presume that even though there is a prob-
ability that HPV can spread to the oral cavities of chil-
dren via vertical transmission, it will not persist until
their adulthood. Most likely, the HPV DNA that
detected right after their delivery was due to contamina-
tion, as suggested in other studies.
Conclusion
This study shows that there is low, if any, risk of HR-
HPV infection in oral cavity of women with cervical
cancer. There were no relevant risk factors that contrib-
uted to the development of this infection. Further, our
study suggests that there is very low risk for children of
women with cervical cancer, to acquire and sustain HR-
HPV in their oral cavity until childhood or adolescence.
More studies with bigger sample size are recommended
to determine the relationship of HPV infection in these
two areas. For more accurate evaluation of vertical
transmission, long term follow-up studies should be
conducted.
Methods
Study Design and data collection
This was a cross-sectional study that involved 70 women
who were diagnosed to have cervical cancer, undergoing
active treatment and routine follow up in Obstetrics and
Gynaecology department or Oncology department of
Hospital Universiti Sains Malaysia. A total of 46 children
of these women, born only with vaginal delivery, were
also examined. Only those children, who were born after
the women were suspected or diagnosed of cervical can-
cer, were recruited in this study. Ethical approval was
obtained from the Human Research Ethics Committee of
Universiti Sains Malaysia. After obtaining the consent
and explaining the procedure to each participant, ques-
tions about sociodemographics, marital status, reproduc-
tive history, tobacco or alcohol usage, contraceptive pills
usage, oral and medical health status were asked using
questionnaire provided to women at the time of enroll-
ment. The questionnaire given to children was to inquire
about their sociodemographic profile and habits. The
children, who were older than 18 years of age, were mar-
ried, or in any immunocompromised state like diabetes,
were excluded from this study. Oral cavity of the subjects
was also checked for any oral lesions, including HPV
related oral lesions like papillomas, condylomas and focal
epithelial hyperplasia, by a single oral medicine specialist
to avoid inter-examiner variability.
Sample collection and testing
The buccal swabs were collected using DNAPap Cervi-
cal Sampler™,f r o mr i g h ta n dl e f tb u c c a lm u c o s ab y
moving the brush in circular motions, and then kept in
the transport medium. All the sample tubes were stored
immediately in -20°C until testing for HPV. All collected
specimens were tested using Hybrid Capture 2® (HC2)
high-risk (HR) HPV DNA detection system located in
the Department of Pathology, Universiti Sains Malaysia,
and the procedure followed was according to the
instruction of manufacturer. Digene HC2® detects HR-
HPV (Qiagen, U.S.A.) by using RNA probe cocktails to
detect 13 HPV-HR which are HPV type-16, 18, 31, 33,
35, 39, 45, 51, 52, 56, 58, 59 and 68. HC2® technology is
a nucleic acid hybridization assay for detection of HPV
with signal amplification using microplate chemilumi-
nescent detection. Light emitted is measured in terms of
relative light units (RLUs) using Luminometer. RLU
value is converted into ratio by the Cutoff value (5000
copies/ml). Any specimen with RLU/CO ≥1 was consid-
ered positive.
Statistical Analysis
T h ep r e v a l e n c eo fH P Vi nt h eo r a lc a v i t yo fc e r v i c a l
cancer subjects was analysed using estimation method.
The association of HPV infection with risk factors
(sociodemographic profile, marital status, reproductive
history, tobacco and/or alcohol habits, contraceptive
pills usage and any oral lesions) was analyzed using Chi
square test/Fisher’s exact test with software SPSS ver-
sion 16.0.
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